Figure 7

2D molecular interactions of MRTX1133 and selected compounds within the binding site of KRAS allosteric binding site. The selected compounds and MRTX1133 show similar interactions with the binding site residues suggesting the selected compounds have the potential to elicit similar therapeutic effects.